CA19-9评估小肠腺癌1例报道  

Evaluation of CA19-9 in small-intestine adenocarcinoma: one case report

作　　者：沈媛媛[1] 程凯[2] 马锋振[1] 刘成霞[1] 

机构地区：[1]山东省滨州医学院附属医院消化内科,山东滨州256600 [2]山东省滨州医学院附属医院甲状腺乳腺外科,山东滨州256600

出　　处：《胃肠病学和肝病学杂志》2016年第3期347-347,351,共2页Chinese Journal of Gastroenterology and Hepatology

摘　　要：小肠肿瘤是一种发病率低,但恶性程度极高的肿瘤,在病理类型中,以小肠腺癌为最多见。由于缺乏典型的临床表现,小肠腺癌发现时往往已处于晚期。目前越来越多的技术应用在小肠腺癌的早期诊断及预后评价中,CA19-9是一种常见、低廉的检查手段,本研究旨在探讨其在小肠腺癌早期诊断及预后评价中的作用。Small-intestine carcinoma is a high malignant disease with low incidence and mainly includes adenocarcinoma in pathological pattern. As lack of typical symptom,small-intestine adenocarcinoma is diagnosed in late phase. However,more and more techniques have been used in early diagnosis and prognosis of small intestine adenocarcinoma. CA19-9,which is a common and cheap examination,was investigated in this study in early diagnosis and prognosis of small-intestine adenocarcinoma.

关 键 词：小肠腺癌 CA19-9 早期诊断 预后评价 

分 类 号：R735.3[医药卫生—肿瘤]